These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 14666694)
121. Sonic hedgehog signaling promotes motility and invasiveness of gastric cancer cells through TGF-beta-mediated activation of the ALK5-Smad 3 pathway. Yoo YA; Kang MH; Kim JS; Oh SC Carcinogenesis; 2008 Mar; 29(3):480-90. PubMed ID: 18174246 [TBL] [Abstract][Full Text] [Related]
122. Tranilast (N-(3,4-dimethoxycinnamoyl) anthranilic acid) down-regulates the growth of scirrhous gastric cancer. Yashiro M; Chung YS; Sowa M Anticancer Res; 1997; 17(2A):895-900. PubMed ID: 9137424 [TBL] [Abstract][Full Text] [Related]
125. Sensitivity of scirrhous gastric cancer to 5-fluorouracil and the role of cancer cell-stromal fibroblast interaction. Nakajima K; Okita Y; Matsuda S Oncol Rep; 2004 Jul; 12(1):85-90. PubMed ID: 15201964 [TBL] [Abstract][Full Text] [Related]
126. Tranilast (N-3,4-dimethoxycinamoyl anthranilic acid): a novel inhibitor of invasion-stimulating interaction between gastric cancer cells and orthotopic fibroblasts. Yashiro M; Murahashi K; Matsuoka T; Nakazawa K; Tanaka H; Osaka H; Koyama T; Ohira M; Chung KH Anticancer Res; 2003; 23(5A):3899-904. PubMed ID: 14666694 [TBL] [Abstract][Full Text] [Related]
127. Role of myofibroblasts at the invasion front. De Wever O; Mareel M Biol Chem; 2002 Jan; 383(1):55-67. PubMed ID: 11928823 [TBL] [Abstract][Full Text] [Related]
128. Therapeutic potential of tranilast, an anti-allergy drug, in proliferative disorders. Rogosnitzky M; Danks R; Kardash E Anticancer Res; 2012 Jul; 32(7):2471-8. PubMed ID: 22753703 [TBL] [Abstract][Full Text] [Related]
129. Anti-cancer effects of Tranilast: An update. Osman S; Raza A; Al-Zaidan L; Inchakalody VP; Merhi M; Prabhu KS; Abdelaziz N; Hydrose S; Uddin S; Dermime S Biomed Pharmacother; 2021 Sep; 141():111844. PubMed ID: 34174504 [TBL] [Abstract][Full Text] [Related]